{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:25:40Z","timestamp":1772825140409,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jjcc.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T01:28:14Z","timestamp":1636507694000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0959-8603","authenticated-orcid":false,"given":"Amel","family":"Allou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Baschet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Sabourin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalscot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Lorgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Iriart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2021.10.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.117.017640","article-title":"National trends in patients hospitalized for stroke and stroke mortality in France, 2008 to 2014","volume":"48","author":"Lecoffre","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0002","unstructured":"HAS. Pr\u00e9vention vasculaire apr\u00e8s un infarctus c\u00e9r\u00e9bral ou un accident isch\u00e9mique transitoire. 2018."},{"key":"10.1016\/j.jjcc.2021.10.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2018.08.004","article-title":"Patent foramen ovale: a comprehensive review","volume":"45","author":"Teshome","year":"2020","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2015-307639","article-title":"Patent foramen ovale: the current state of play","volume":"101","author":"Asrress","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fneur.2020.00281","article-title":"Epidemiology of patent foramen ovale in general population and in stroke patients: a narrative review","volume":"11","author":"Koutroulou","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003771","article-title":"Patent foramen ovale with atrial septal aneurysm is strongly associated with migraine with aura: a large observational study","volume":"5","author":"Snijder","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0007","doi-asserted-by":"crossref","first-page":"53242","DOI":"10.1016\/j.acvd.2019.06.002","article-title":"Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: expert consensus of the French Neurovascular Society and the French Society of Cardiology","volume":"112","author":"Mas","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0009","doi-asserted-by":"crossref","first-page":"19424","DOI":"10.1161\/01.CIR.99.15.1942","article-title":"Frequency of atrial septal aneurysms in patients with cerebral ischemic events","volume":"99","author":"Agmon","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE Study","volume":"7","author":"Turc","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"40","author":"Pristipino","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0014","unstructured":"HAS. Avis d'efficience d'Amplatzer PFO du 17 d\u00e9cembre 2019. 2019."},{"key":"10.1016\/j.jjcc.2021.10.009_bib0015","doi-asserted-by":"crossref","first-page":"65665","DOI":"10.1080\/13696998.2018.1456445","article-title":"Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention","volume":"21","author":"Tirschwell","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0016","unstructured":"HAS. Guide m\u00e9thodologique. Choix m\u00e9thodologiques pour l\u2019\u00e9valuation \u00e9conomique \u00e0 la HAS. 2011."},{"key":"10.1016\/j.jjcc.2021.10.009_bib0017","doi-asserted-by":"crossref","first-page":"90313","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0018","series-title":"Commissioning through evaluation (cte) percutaneous closure of patent foramen ovale (pfoc) to prevent recurrent cerebral embolic events","year":"2018"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182a9f45f","article-title":"Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study","volume":"81","author":"Luengo-Fernandez","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0020","doi-asserted-by":"crossref","first-page":"88390","DOI":"10.1080\/13696998.2019.1611587","article-title":"Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective","volume":"22","author":"Volpi","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.117.020322","article-title":"Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke prevention","volume":"49","author":"Leppert","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0022","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10557-020-07068-9","article-title":"Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis","volume":"35","author":"Angelini","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0023","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1161\/STROKEAHA.120.031237","article-title":"Dabigatran or aspirin after embolic stroke of undetermined source in patients with patent foramen ovale: results from RE-SPECT ESUS","volume":"52","author":"Diener","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0024","unstructured":"INSEE. Donn\u00e9es d\u00e9taill\u00e9es des statistiques d\u2019\u00e9tat civil sur les d\u00e9c\u00e8s en 2017. 2018."},{"key":"10.1016\/j.jjcc.2021.10.009_bib0025","first-page":"1749","article-title":"Co\u00fbt direct des AVK en France","volume":"8","author":"Detournay","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13613-020-00760-x","article-title":"Sepsis and septic shock in France: incidences, outcomes and costs of care","volume":"10","author":"Dupuis","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0027","first-page":"807","article-title":"Clinical and economic outcomes of infective endocarditis","volume":"47","author":"Sunder","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12143","article-title":"Cost of stroke in France","volume":"20","author":"Chevreul","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0029","series-title":"Etude r\u00e9alis\u00e9e pour le compte de la F\u00e9d\u00e9ration nationale des transporteurs sanitaires (sur la p\u00e9riode 2008-2014)","author":"Begriche","year":"2016"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0030","series-title":"Direction de la Recherche, des \u00c9tudes, de l'\u00c9valuation et des Statistiques. Les b\u00e9n\u00e9ficiaires d'une pension d'invalidit\u00e9","year":"2014"},{"key":"10.1016\/j.jjcc.2021.10.009_bib0031","series-title":"Caisse nationale de l'assurance maladie des travailleurs salari\u00e9s. Arr\u00eats de travail pour maladie\u00a0: exemples de travaux \u00e0 partir des donn\u00e9es du Sniiram","author":"Culinot","year":"2012"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872100280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872100280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:06:30Z","timestamp":1760274390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872100280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S091450872100280X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.10.009","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}